Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Yuri Lopatin"'
Autor:
Alberto Palazzuoli, Marco Metra, Sean P. Collins, Marianna Adamo, Andrew P. Ambrosy, Laura E. Antohi, Tuvia Ben Gal, Dimitrios Farmakis, Finn Gustafsson, Loreena Hill, Yuri Lopatin, Francesco Tramonte, Alexander Lyon, Josep Masip, Oscar Miro, Brenda Moura, Wilfried Mullens, Razvan I. Radu, Magdy Abdelhamid, Stefan Anker, Ovidiu Chioncel
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 3713-3736 (2022)
Abstract The coronavirus 2019 (COVID‐19) infection pandemic has affected the care of patients with heart failure (HF). Several consensus documents describe the appropriate diagnostic algorithm and treatment approach for patients with HF and associa
Externí odkaz:
https://doaj.org/article/f52dd99e17794c7e9f1e8076d1fb0a29
Autor:
Giuseppe M.C. Rosano, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Yuri Lopatin, Fin Gustafsson, Antoni Bayes‐Genis, Tiny Jaarsma, Magdy Abdelhamid, Arantxa Gonzalez Miqueo, Massimo Piepoli, Carlo G. Tocchetti, Arsen D. Ristić, Ewa Jankowska, Brenda Moura, Loreena Hill, Gerasimos Filippatos, Marco Metra, Davor Milicic, Thomas Thum, Ovidiu Chioncel, Tuvia Ben Gal, Lars H. Lund, Dimitrios Farmakis, Wilfried Mullens, Stamatis Adamopoulos, Michael Bohm, Anna Norhammar, Andreas Bollmann, Amitava Banerjee, Aldo P. Maggioni, Adriaan Voors, Alain Cohen Solal, Andrew J.S. Coats
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 2767-2778 (2022)
Abstract Heart failure (HF) is a long‐term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and mor
Externí odkaz:
https://doaj.org/article/d082594880a44faf89c82613271970d4
Autor:
Razvan I. Radu, Tuvia Ben Gal, Magdy Abdelhamid, Elena‐Laura Antohi, Marianna Adamo, Andrew P. Ambrosy, Oliviana Geavlete, Yuri Lopatin, Alexander Lyon, Oscar Miro, Marco Metra, John Parissis, Sean P. Collins, Stefan D. Anker, Ovidiu Chioncel
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4717-4736 (2021)
Abstract Cardiogenic shock (CS) is a complex multifactorial clinical syndrome, developing as a continuum, and progressing from the initial insult (underlying cause) to the subsequent occurrence of organ failure and death. There is a large phenotypic
Externí odkaz:
https://doaj.org/article/d655f69a7f10400792deeb84af7d8578
Autor:
Markus S. Anker, Claire Bouleti, Theodoros Christodoulides, Angela Durante, Edit Gara, Sara Hadzibegovic, Kalliopi Keramida, Alessia Lena, Angela Massouh, Ivan Milinkovic, Matthias P. Nägele, Alexander Nossikoff, Rui Plácido, Tamás Radovits, Heli Tolppanen, Giuseppe Vergaro, Markus Wallner, Sophie Welch, Yuri Lopatin, Mitja Lainscak, Alexandre Mebazaa, Andrew J.S. Coats, Petar M. Seferović, Ewa A. Jankowska, for the Heart Failure Association Committee on Heart Failure Specialists of Tomorrow of the European Society of Cardiology
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 873-877 (2020)
Abstract The “Heart failure specialists of Tomorrow” (HoT) group gathers young researchers, physicians, basic scientists, nurses and many other professions under the auspices of the Heart Failure Association of the European Society of Cardiology.
Externí odkaz:
https://doaj.org/article/f698a14eda164587aac6cf496cba97c3
Autor:
Carolyn S. P. Lam, Hillary Mulder, Yuri Lopatin, Jose B. Vazquez‐Tanus, David Siu, Justin Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
Background Although safety and tolerability of vericiguat were established in the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) trial in patients with heart failure with reduced ejection fraction, so
Externí odkaz:
https://doaj.org/article/746573cb9e5446779c083cce06f77a82
Publikováno v:
International Cardiovascular Forum Journal, Vol 18, Pp 23-26 (2019)
Hospitalized and stable HF patients are both at increased risk of thrombo-embolic events, making the possibility of protection via the use of anticoagulants and/or antithrombotics attractive. The 2016 ESC guidelines on HF, do not recommend aspirin or
Externí odkaz:
https://doaj.org/article/b4097866c18f4895be67fcfbf1f9bd3f
Autor:
Yuri Lopatin, Giuseppe MC Rosano
Publikováno v:
International Cardiovascular Forum Journal, Vol 10, Pp 37-40 (2017)
The clinical course of heart failure includes a period in which the patient is at increased risk of death or rehospitalisation for HF. This period is termed the “vulnerable phase” and occurs during the peri-acute HF phase, due to microenvironment
Externí odkaz:
https://doaj.org/article/2896f32cbd1c46c5a10c013ade80d3ff
Autor:
Yuri Lopatin, Andrew J Stewart Coats
Publikováno v:
International Cardiovascular Forum Journal, Vol 10, Pp 63-64 (2017)
Kidney dysfunction and other related abnormalities are extremely common in all HF syndromes, both because of the similarity of risk factors and the similarity of demography of the two types of patients but also because of the common renal effects of
Externí odkaz:
https://doaj.org/article/0a493a3672e94a2486f83034dd35fc51
Publikováno v:
International Cardiovascular Forum Journal, Vol 10, Pp 68-69 (2017)
The 2016 ESC/HFA HF guidelines carry an important section on the treatments of co- morbidities in HF. Foremost of these in terms of frequency and its relevance to the aetiology of HF, especially HFpEF is hypertension. In this artcile we will review w
Externí odkaz:
https://doaj.org/article/d1c2ce8f341f460e86a1a0ef1e0a013c
Autor:
Ekaterina Kartamyscheva, Yuri Lopatin
Publikováno v:
Rational Pharmacotherapy in Cardiology. 18:510-515
Aim. To research the effect of structured telephone support on the self-care in comorbid patients with chronic heart failure (CHF) over 12 months of follow-up.Material and methods. Self-care was assessed using The Self-care of Heart Failure Index (SC